Key Points
- McKesson EVP Thomas Rodgers sold 699 shares on June 2 at an average price of $735.27, generating about $513,954. After the transaction, he held 2,268 shares, a 23.56% reduction, and the sale was made under a pre-arranged Rule 10b5-1 plan.
- The company recently reported strong quarterly earnings, posting $11.69 EPS versus analyst expectations of $11.56. Revenue came in at $96.30 billion, up 6% year over year, though it missed consensus estimates.
- McKesson also announced a quarterly dividend of $0.82 per share, payable July 1, which works out to an annualized dividend of $3.28 and a yield of about 0.4%.
McKesson Corporation (NYSE:MCK - Get Free Report) EVP Thomas Rodgers sold 123 shares of the business's stock in a transaction that occurred on Monday, June 1st. The shares were sold at an average price of $735.50, for a total value of $90,466.50. Following the completion of the transaction, the executive vice president directly owned 2,967 shares in the company, valued at approximately $2,182,228.50. This trade represents a 3.98% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
McKesson Stock Up 0.5%
Shares of NYSE:MCK opened at $740.43 on Thursday. McKesson Corporation has a twelve month low of $637.00 and a twelve month high of $999.00. The stock's 50 day moving average is $810.87 and its 200-day moving average is $850.07. The firm has a market capitalization of $89.00 billion, a price-to-earnings ratio of 19.25, a PEG ratio of 1.10 and a beta of 0.31.
McKesson (NYSE:MCK - Get Free Report) last issued its earnings results on Thursday, May 7th. The company reported $11.69 earnings per share for the quarter, topping analysts' consensus estimates of $11.56 by $0.13. McKesson had a negative return on equity of 345.35% and a net margin of 1.18%.The company had revenue of $96.30 billion for the quarter, compared to analyst estimates of $101.35 billion. During the same period in the prior year, the firm earned $10.12 earnings per share. McKesson's revenue for the quarter was up 6.0% on a year-over-year basis. McKesson has set its FY 2027 guidance at 43.800-44.600 EPS. Equities research analysts anticipate that McKesson Corporation will post 44.29 earnings per share for the current fiscal year.
McKesson Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Wednesday, July 1st. Stockholders of record on Monday, June 1st will be given a dividend of $0.82 per share. This represents a $3.28 dividend on an annualized basis and a dividend yield of 0.4%. The ex-dividend date of this dividend is Monday, June 1st. McKesson's dividend payout ratio is presently 8.53%.
Analyst Upgrades and Downgrades
A number of brokerages have recently weighed in on MCK. Citigroup lowered their target price on McKesson from $975.00 to $945.00 and set a "buy" rating on the stock in a research report on Thursday, May 14th. UBS Group upped their price target on McKesson from $1,000.00 to $1,050.00 and gave the stock a "buy" rating in a report on Friday, May 8th. Wells Fargo & Company decreased their price target on McKesson from $925.00 to $812.00 and set an "equal weight" rating for the company in a report on Tuesday, May 12th. Barclays upped their price target on McKesson from $960.00 to $1,050.00 and gave the stock an "overweight" rating in a report on Wednesday, February 18th. Finally, TD Cowen upped their price target on McKesson from $1,000.00 to $1,012.00 and gave the stock a "buy" rating in a report on Thursday, February 5th. Fourteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $968.87.
View Our Latest Stock Report on McKesson
Institutional Investors Weigh In On McKesson
Several institutional investors have recently bought and sold shares of the stock. Parallel Advisors LLC grew its holdings in McKesson by 3.0% during the first quarter. Parallel Advisors LLC now owns 2,878 shares of the company's stock worth $2,491,000 after buying an additional 83 shares in the last quarter. First Nebraska Trust Co bought a new position in McKesson in the 1st quarter valued at $723,000. Lavelle Capital LP purchased a new stake in shares of McKesson during the 1st quarter valued at $398,000. Alpine Woods Capital Investors LLC raised its stake in shares of McKesson by 45.8% during the 1st quarter. Alpine Woods Capital Investors LLC now owns 856 shares of the company's stock worth $741,000 after purchasing an additional 269 shares during the period. Finally, Allen Capital Group LLC raised its stake in shares of McKesson by 17.7% during the 1st quarter. Allen Capital Group LLC now owns 333 shares of the company's stock worth $288,000 after purchasing an additional 50 shares during the period. Institutional investors own 85.07% of the company's stock.
McKesson Company Profile
(
Get Free Report)
McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.
The company's core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
